Home » today » Health » Experts Warn of Increased Risk of Mosquito Invasion and Dengue Outbreak in Argentina

Experts Warn of Increased Risk of Mosquito Invasion and Dengue Outbreak in Argentina

There is a great possibility of suffering a new invasion of mosquitoes during the next few days. Recent rains refilled the wells and ponds with water, where the eggs are. And this time it may also happen that the number of insects of the species increases. temples of the Egyptians, responsible for the spread of dengue, chikungunya and Zika. For this reason, specialists already recommend taking precautionary measures for the rest of the week.

“This time we will not have the Aedes albifasciatus mosquito, which is the of the flood. What there is now is a great abundance of aegypti, which is the vector of dengue,” he tells Clarion Victoria Micieli, biologist with a focus on zoology. And she explains that “there are many breeding sites – those artificial containers of the dengue vector – that were filled with water; and it makes the eggs hatch. That will cause an increase in the abundance of aegypti”.

Dengue cases

The biochemist, expert in vaccines and Conicet researcher, Daniela Hozbor, warned that in Argentina they increased 2,500% of dengue cases. The researcher indicated that “climate change and the increase in temperature favor greater mosquito reproduction. In the northeast of the country there were cases all year round, so we have to be vigilant. “In La Plata there is already an alert for the outbreak.”

He also pointed out that the dengue vaccine must provide protection against the four serotypes of dengue. “Serious illness occurs when you have a second infection and with a different variant than the first. In Argentina, a vaccine of Japanese origin is authorized. It is safe and is indicated from 4 to 60 years of age. For now he is in the private sector.”

According to the latest National Epidemiological Bulletin, in one year 57,210 cases of dengue were registered in Argentina: 52,770 without travel history (native), 2,497 imported and 1,943 under investigation, resulting in a cumulative incidence so far at the country level of 121 cases per hundred thousand inhabitants. In the same period, 118 cases were classified as severe dengue (0.20%), and there were 38 deaths. Currently, 17 jurisdictions have reported viral circulation in their territory.

Although cases of dengue were recorded in all age groups, between 15 and 69 years of age the cumulative incidence is higher than in the general population (121) and decreases towards the ends of life. The minimum cumulative incidence is observed in children under 4 years of age, with 31 cases per 100,000 inhabitants, and a maximum of 162 cases per 100,000 inhabitants between 25 and 34 years of age.

In one year, 38 people died from dengue, of which 28 belong to the year 2024. And they are concentrated in the provinces of Chaco (12), Corrientes (6), Formosa (5), Misiones (12), Buenos Aires (1) , Santa Fe (1) and Santiago del Estero (1). In 20 of the cases the serotype involved could be determined: 12 cases corresponded to the DENV-2 serotype and 8 cases to the DENV-1 serotype.

Who should be vaccinated against dengue?

Dengue is spread when the mosquito feeds on the blood of a sick person and then bites others and transmits the infection that causes the disease. It is never spread from one person to another, not through objects or breast milk.

The dengue vaccine consists of two doses separated by a minimum interval of three months. Specialists consulted by Clarion They explain who should apply it, how long it provides immunity and how long that protection lasts.

“The vaccine can be applied from the age of 4 and without age limit. It is contraindicated for pregnant women, breastfeeding women and immunosuppressed people,” Eduardo López, pediatric infectious disease doctor and head of the Department of Medicine at the Ricardo Gutiérrez Children’s Hospital, tells this newspaper.

According to the specialist, people who have already had dengue will benefit the most from the vaccine, since protection is essential for them, taking into account that it is very risky to get infected again. “This group should have priority, although the reality is that there are people who had dengue asymptomatically and do not know it,” says López.

“Immunity is achieved 10 days after the application of the second dose, however, surely a certain level of antibodies will develop from the first application,” says the infectious disease specialist.

consulted by Clarion, the Buenos Aires Minister of Health, Fernán Quiros, expressed that the decision to apply the vaccine en masse will be made after the National Immunization Commission (CoNain) gives the go-ahead. That organization decided to wait about eight months to find out on the ground the effectiveness of the vaccine. So there would be definitions in the middle of this year.

As main conclusions, The application of 2 doses of the vaccine showed an 84% reduction in dengue hospitalizations and a 61% decrease in symptomatic dengue cases.

The vaccine was approved by ANMAT in April of last year, and its incorporation into a national vaccination strategy is a definition that requires information and scientific evidence to be able to establish its effectiveness, and at what ages the best results are obtained.

To date, the National Immunization Commission (CoNaIn) recommended carrying out an evaluation of witness cases and experiences that are developing in the areas with the greatest circulation of the country and in the countries of the region, which allows arriving at a definition for the formulation of a national strategy.

And in this instance, work is being done from the Ministry of Health of the Nation, in coordination with the provincial health authorities. In addition to reinforcing actions for surveillance, prevention, control and monitoring of the epidemiological situation.

Symptoms

Dengue is a viral disease transmitted by mosquitoes, whose main vector is the Aedes aegypti species. Currently, it constitutes a major threat to global public health, with risk of infection in more than 125 countries, including many in Latin America. Severe dengue has become one of the main causes of hospitalization and death among children and adults in some countries in the region.

Among the main symptoms are fever, severe headache, pain behind the eyes, muscle and joint pain, diarrhea and vomiting. It can also cause skin rashes.

2024-02-29 16:46:34
#mosquito #invasion #expected #time #concern #dengue

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.